After decades of supporting the “war on drugs,” the Republican Party has begun embracing psychedelics for mental health treatment, driven largely by military veterans and high-profile advocates. In April 2026, President Donald Trump signed an executive order promoting increased research into psychedelics, signaling a major shift in federal policy.
The Path to Presidential Action
The rapid rise came through an unusual channel: On Joe Rogan’s podcast in late March, former Texas Governor Rick Perry and ibogaine advocate W. Bryan Hubbard asked Rogan to arrange a presidential meeting. Less than three weeks later, Hubbard was standing in the Oval Office as Trump announced efforts to accelerate research into ibogaine and fast-track federal reviews of other psychedelic medicines. The interaction reportedly began when Trump texted Rogan: “Sounds great. Do you want FDA approval? Let’s do it.”
Administration Support and Clinical Progress
High-ranking officials including Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary have championed psychedelics. Kennedy became open to psychedelics because he believes the ayahuasca plant mixture helped his son process his mother’s suicide. The administration has been closely watching a $50 million investment in ibogaine research in Texas, billed as the largest such public investment. One week after the April 18 executive order, three companies—two studying psilocybin for depression and another studying methylone for PTSD—received priority vouchers from the FDA.
Veteran Advocacy and State Legislation
Veterans, who typically have clout with the GOP, pushed the issue. Marcus Capone, who served as a Navy SEAL for 13 years, was struggling with depression, alcohol use, and traumatic brain injury when he traveled to Mexico in 2017 to try ibogaine in a supervised setting. Subsequent improvements prompted him and Amber Capone to create Veterans Exploring Treatment Solutions, a nonprofit advocating for greater psychedelic access. The veteran community has “really come out and led the charge,” according to advocates, making “it really hard to refute veteran stories.”
State lawmakers from both parties have worked on legislation. Texas Governor Greg Abbott green-lit spending up to $50 million for ibogaine research last summer. California Governor Gavin Newsom signed a bill to ease psychedelic drug studies. Utah Governor Spencer Cox approved legislation authorizing a study of psychedelic-assisted therapy for veterans with PTSD in March.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://us.headtopics.com/news/how-republicans-came-to-embrace-psychedelic-drugs-82987290